Covered recipient · General Payments record
ALFRED JAMES SCHLORKE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,155.90
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $538.42 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $244.33 | 18 |
| ABBVIE INC. | $77.21 | 3 |
| Novo Nordisk AS | $65.54 | 4 |
| Astellas Pharma US Inc | $42.04 | 2 |
| Acerta Pharma LLC | $36.01 | 2 |
| Supernus Pharmaceuticals, Inc. | $27.88 | 2 |
| Seqirus USA Inc | $18.55 | 1 |
| Axsome Therapeutics, Inc. | $13.63 | 1 |
| Lilly USA, LLC | $13.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.09 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106035694 | CMS |
| ABBVIE INC. | $19.03 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106035696 | CMS |
| ABBVIE INC. | $30.09 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106035698 | CMS |
| Astellas Pharma US Inc | $22.52 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139335700 | CMS |
| Astellas Pharma US Inc | $19.52 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139266742 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.56 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104496602 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.45 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105499644 | CMS |
| Axsome Therapeutics, Inc. | $13.63 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148262625 | CMS |
| Lilly USA, LLC | $13.23 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136021272 | CMS |
| Novo Nordisk Inc | $13.40 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096602323 | CMS |
| Novo Nordisk Inc | $18.78 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096995844 | CMS |
| Novo Nordisk Inc | $13.70 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096952700 | CMS |
| Novo Nordisk Inc | $19.66 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096850212 | CMS |
| PFIZER INC. | $13.23 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131102743 | CMS |
| PFIZER INC. | $14.70 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131021210 | CMS |
| PFIZER INC. | $16.86 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131151758 | CMS |
| PFIZER INC. | $11.88 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131714397 | CMS |
| PFIZER INC. | $12.41 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131714576 | CMS |
| PFIZER INC. | $15.27 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131314934 | CMS |
| PFIZER INC. | $14.18 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131453049 | CMS |
| PFIZER INC. | $12.65 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131727697 | CMS |
| PFIZER INC. | $11.49 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131777824 | CMS |
| PFIZER INC. | $15.16 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131758806 | CMS |
| PFIZER INC. | $10.15 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131862387 | CMS |
| PFIZER INC. | $11.39 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131875311 | CMS |
| PFIZER INC. | $12.28 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131980571 | CMS |
| PFIZER INC. | $13.72 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132100131 | CMS |
| PFIZER INC. | $11.39 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132116428 | CMS |
| PFIZER INC. | $15.19 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131109028 | CMS |
| PFIZER INC. | $15.19 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131207961 | CMS |
| PFIZER INC. | $17.19 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131214658 | CMS |
| Seqirus USA Inc | $18.55 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125632184 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.33 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147876807 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.55 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147902068 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.